MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, announced an investment of €62 million at its Darmstadt headquarters in a new quality control building for its life science business. The facility will bring together approximately 135 employees across several departments into one collaborative state-of-the-art space. The nearly 10,000 square meter building is scheduled for completion by mid-2025. The new building is part of an investment program at the ...